SentiSense
Ctrl+K
Quick tip: Press
to search stocks
L
LLY
Eli Lilly and Company
$985.08
+7.83 (+0.80%)
Summary
Stories
News
Metrics
Fundamentals
Holders
Full institutional holders data is a Pro feature
UpgradeInstitutional Holders
3834
tracked filers
Total Institutional Value
$321.8B
3834 holders tracked
Report Date
Q4 2025
SEC 13F-HR filing
Notable changes (1)
| Holder | Category | Shares | Value | Weight | Change |
|---|---|---|---|---|---|
LILLY ENDOWMENT INC | Endowment | 95.5M | $72.9B | -- | -0.6% |
STATE STREET CORP | Index Fund | 34.7M | $26.5B | -- | +0.6% |
Capital Research Global Investors | Mutual Fund | 25.1M | $19.1B | -- | +20.9% |
GEODE CAPITAL MANAGEMENT, LLC | Index Fund | 17.7M | $13.4B | -- | +9.9% |
FMR LLC | Other | 17.0M | $12.9B | -- | -7.2% |
Data source: SEC EDGAR 13F-HR filings
Company Profile
Symbol
LLY
Market Cap
$872.68B
IPO Date
Jul 9, 1970
CEO
--
Employees
50,000
Sector
--
Industry
PHARMACEUTICAL PREPARATIONS
Country
United States
Exchange
--
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Read MoreSimilar Stocks
AMGN
Amgen Inc.
$366.21
-0.43%
ZTS
Zoetis Inc.
$115.62
+0.14%
VRTX
Vertex Pharmaceuticals Incorporated
$469.34
-1.84%